Playtime prescription: new study tests if parent-led activity boosts health in kids with heart conditions
NCT ID NCT04619745
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tested whether a 6-month, parent-led physical activity program at home helps young children (ages 3 months to 6 years) born with heart defects get the recommended 180 minutes of daily activity after heart surgery or catheterization. The study enrolled 43 children and focused on whether it's possible to recruit families, collect data, and deliver the program. It's a first step toward a larger trial to see if this approach really improves motor skills and activity levels.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- Individualized home and play-based physical activity plans
- What this could lead to
- If successful, this could pave the way for a larger trial that helps children with heart defects stay active and healthy.
- What could go wrong
- This is a small feasibility study with only 43 participants, so results may not apply to all children. The program may not increase activity levels as hoped.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
43 people
The number who actually took part.
- Started
-
Nov 2020
- Finished
-
Oct 2025
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
3 to 72 months
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria 1. Female or male at least 3 months of age but not more than 72 months of age (upper age limit for valid Peabody Motor Development Scales-2 assessment) 2. Receiving elective treatment via cardiac surgery or catheterization intervention for CHD at the Children's Hospital of Eastern Ontario. Exclusion Criteria 1. Genetic conditions or physical disabilities impacting motor development (e.g., Down syndrome) 2. Emergency treatment for child in critical condition 3. Medical care not compatible with study assessments 4. No independent limb movement.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Congenital heart defect are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Children's Hospital of Eastern Ontario
Ottawa, Ontario, K1H 8L1, Canada
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Peer support by phone may help heart patients take charge of their health
- AI could help heart surgery patients get the right Anti-Inflammatory drug
- Swiss registry tracks adults with congenital heart disease to uncover hidden risks
- Can heart scans predict trouble in tetralogy of fallot patients?
- Antihistamine may shield kids from transfusion danger during heart surgery
- New app aims to ease Parents' stress over Baby's heart surgery decision